REGN
Regeneron Pharmaceuticals Inc
Price:  
673.60 
USD
Volume:  
596,743.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Relative Valuation

4.8%
Upside

As of 2025-02-17, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 706.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 673.60 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 4.8%.

The range of the Relative Valuation is 674.08 - 773.92 USD.

Range Selected
Trailing P/E multiples 16.7x - 17.4x 17.0x
Forward P/E multiples 15.6x - 17.9x 16.8x
Fair Price 674.08 - 773.92 706.21
Upside 0.1% - 14.9% 4.8%
673.60 USD
Stock Price
706.21 USD
Fair Price

Regeneron Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 16.69
2025-02-13 16.70
2025-02-12 16.45
2025-02-11 16.49
2025-02-10 17.10
2025-02-07 17.59
2025-02-06 17.89
2025-02-05 17.76
2025-02-04 17.27
2025-02-03 16.52
2025-01-31 16.67
2025-01-30 16.92
2025-01-29 17.03
2025-01-28 17.00
2025-01-27 16.96
2025-01-24 16.74
2025-01-23 17.21
2025-01-22 16.85
2025-01-21 17.04
2025-01-17 16.89
2025-01-16 17.17
2025-01-15 17.43
2025-01-14 17.12
2025-01-13 17.76
2025-01-10 17.26
2025-01-08 18.17
2025-01-07 18.09
2025-01-06 17.74
2025-01-03 17.79
2025-01-02 17.72
2024-12-31 17.65
2024-12-30 17.41
2024-12-27 17.65
2024-12-26 17.76
2024-12-24 17.70
2024-12-23 17.72
2024-12-20 17.39
2024-12-19 17.55
2024-12-18 17.70
2024-12-17 18.33
2024-12-16 17.96
2024-12-13 18.12
2024-12-12 18.36
2024-12-11 19.15
2024-12-10 19.29
2024-12-09 19.52
2024-12-06 19.27
2024-12-05 19.02
2024-12-04 18.69
2024-12-03 18.57